V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.

Saved in:
Bibliographic Details
Title: V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Authors: Styles TM; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Gangadhara S; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Reddy PBJ; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Sahoo A; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Shiferaw A; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Welbourn S; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Kozlowski PA; Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Derdeyn CA; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States., Velu V; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States., Amara RR; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States.
Source: Frontiers in immunology [Front Immunol] 2022 Jul 22; Vol. 13, pp. 914969. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2022.914969